Description of Research: As part of 2 EU-funded consortia (PharmaSea and Ocean Medicines) we are focusing on novel secondary metabolite pathways from bacteria associated with marine invertebrates and sediments. Extract preparations from these isolates have shown anti-convulsant, anti-microbial or anti-inflammatory properties. Through genome sequencing and genetic engineering strategies in parallel with chemistry-guided isolation, we would like to link novel metabolites to the biosynthetic pathways encoding them.

Academic criteria: Applicants must have completed a PhD degree within no more than 5 years in a foundational discipline relevant to the topic. Applicants should have a strong publication record, interpersonal skills, project management experience, and be able to effectively conduct research as part of a multi-disciplinary team.

Application Requirements: The candidate will be under the supervision of Prof. Marla Trindade. Applicants are to submit their CV and covering letter to This email address is being protected from spambots. You need JavaScript enabled to view it..

THE CLOSING DATE FOR APPLICATIONS IS 28 FEBRUARY 2017